vs
Astrana Health, Inc.(ASTH)与ICF International, Inc.(ICFI)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是ICF International, Inc.的2.1倍($950.5M vs $443.7M)。ICF International, Inc.净利率更高(3.9% vs 0.7%,领先3.2%)。Astrana Health, Inc.同比增速更快(42.9% vs -10.6%)。ICF International, Inc.自由现金流更多($68.7M vs $-6.0M)。过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs -5.3%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
ICF International是一家总部位于美国弗吉尼亚州雷斯顿的上市企业,主营咨询与技术服务,为各行业客户提供专业的解决方案支持,业务覆盖多领域的专业咨询及技术落地服务。
ASTH vs ICFI — 直观对比
营收规模更大
ASTH
是对方的2.1倍
$443.7M
营收增速更快
ASTH
高出53.5%
-10.6%
净利率更高
ICFI
高出3.2%
0.7%
自由现金流更多
ICFI
多$74.7M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-5.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $443.7M |
| 净利润 | $6.6M | $17.3M |
| 毛利率 | — | 35.7% |
| 营业利润率 | 1.9% | 6.5% |
| 净利率 | 0.7% | 3.9% |
| 营收同比 | 42.9% | -10.6% |
| 净利润同比 | 184.4% | -29.5% |
| 每股收益(稀释后) | $0.12 | $0.95 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
ICFI
| Q4 25 | $950.5M | $443.7M | ||
| Q3 25 | $956.0M | $465.4M | ||
| Q2 25 | $654.8M | $476.2M | ||
| Q1 25 | $620.4M | $487.6M | ||
| Q4 24 | $665.2M | $496.3M | ||
| Q3 24 | $478.7M | $517.0M | ||
| Q2 24 | $486.3M | $512.0M | ||
| Q1 24 | $404.4M | $494.4M |
净利润
ASTH
ICFI
| Q4 25 | $6.6M | $17.3M | ||
| Q3 25 | $373.0K | $23.8M | ||
| Q2 25 | $9.4M | $23.7M | ||
| Q1 25 | $6.7M | $26.9M | ||
| Q4 24 | $-7.8M | $24.6M | ||
| Q3 24 | $16.1M | $32.7M | ||
| Q2 24 | $19.2M | $25.6M | ||
| Q1 24 | $14.8M | $27.3M |
毛利率
ASTH
ICFI
| Q4 25 | — | 35.7% | ||
| Q3 25 | — | 37.6% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 38.0% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 37.2% |
营业利润率
ASTH
ICFI
| Q4 25 | 1.9% | 6.5% | ||
| Q3 25 | 2.0% | 8.3% | ||
| Q2 25 | 3.1% | 8.4% | ||
| Q1 25 | 3.3% | 7.9% | ||
| Q4 24 | 0.1% | 7.3% | ||
| Q3 24 | 5.9% | 8.9% | ||
| Q2 24 | 6.2% | 8.3% | ||
| Q1 24 | 7.5% | 8.3% |
净利率
ASTH
ICFI
| Q4 25 | 0.7% | 3.9% | ||
| Q3 25 | 0.0% | 5.1% | ||
| Q2 25 | 1.4% | 5.0% | ||
| Q1 25 | 1.1% | 5.5% | ||
| Q4 24 | -1.2% | 4.9% | ||
| Q3 24 | 3.4% | 6.3% | ||
| Q2 24 | 3.9% | 5.0% | ||
| Q1 24 | 3.7% | 5.5% |
每股收益(稀释后)
ASTH
ICFI
| Q4 25 | $0.12 | $0.95 | ||
| Q3 25 | $0.01 | $1.28 | ||
| Q2 25 | $0.19 | $1.28 | ||
| Q1 25 | $0.14 | $1.44 | ||
| Q4 24 | $-0.14 | $1.29 | ||
| Q3 24 | $0.33 | $1.73 | ||
| Q2 24 | $0.40 | $1.36 | ||
| Q1 24 | $0.31 | $1.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $5.3M |
| 总债务越低越好 | — | $401.4M |
| 股东权益账面价值 | $779.3M | $1.0B |
| 总资产 | $2.2B | $2.1B |
| 负债/权益比越低杠杆越低 | — | 0.39× |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
ICFI
| Q4 25 | $429.5M | $5.3M | ||
| Q3 25 | $463.4M | $4.0M | ||
| Q2 25 | $342.1M | $7.0M | ||
| Q1 25 | $260.9M | $5.7M | ||
| Q4 24 | $290.8M | $5.0M | ||
| Q3 24 | $350.3M | $6.9M | ||
| Q2 24 | $327.7M | $4.1M | ||
| Q1 24 | $337.3M | $3.7M |
总债务
ASTH
ICFI
| Q4 25 | — | $401.4M | ||
| Q3 25 | — | $449.4M | ||
| Q2 25 | — | $462.3M | ||
| Q1 25 | — | $502.0M | ||
| Q4 24 | — | $411.7M | ||
| Q3 24 | — | $419.1M | ||
| Q2 24 | — | $433.9M | ||
| Q1 24 | — | $474.7M |
股东权益
ASTH
ICFI
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | $1.0B | ||
| Q2 25 | $765.5M | $1.0B | ||
| Q1 25 | $745.4M | $968.9M | ||
| Q4 24 | $712.7M | $982.5M | ||
| Q3 24 | $704.6M | $976.3M | ||
| Q2 24 | $678.9M | $943.3M | ||
| Q1 24 | $653.5M | $916.1M |
总资产
ASTH
ICFI
| Q4 25 | $2.2B | $2.1B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
负债/权益比
ASTH
ICFI
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.52× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.52× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $75.6M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $68.7M |
| 自由现金流率自由现金流/营收 | -0.6% | 15.5% |
| 资本支出强度资本支出/营收 | 0.3% | 1.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 4.37× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $120.2M |
8季度趋势,按日历期对齐
经营现金流
ASTH
ICFI
| Q4 25 | $-2.9M | $75.6M | ||
| Q3 25 | $10.0M | $47.3M | ||
| Q2 25 | $90.9M | $52.0M | ||
| Q1 25 | $16.6M | $-33.0M | ||
| Q4 24 | $-10.9M | $95.4M | ||
| Q3 24 | $34.0M | $25.5M | ||
| Q2 24 | $23.2M | $60.6M | ||
| Q1 24 | $6.0M | $-10.0M |
自由现金流
ASTH
ICFI
| Q4 25 | $-6.0M | $68.7M | ||
| Q3 25 | $7.4M | $41.8M | ||
| Q2 25 | $89.5M | $46.2M | ||
| Q1 25 | $13.6M | $-36.5M | ||
| Q4 24 | $-13.5M | $89.5M | ||
| Q3 24 | $31.7M | $20.4M | ||
| Q2 24 | $20.4M | $55.5M | ||
| Q1 24 | $5.6M | $-15.2M |
自由现金流率
ASTH
ICFI
| Q4 25 | -0.6% | 15.5% | ||
| Q3 25 | 0.8% | 9.0% | ||
| Q2 25 | 13.7% | 9.7% | ||
| Q1 25 | 2.2% | -7.5% | ||
| Q4 24 | -2.0% | 18.0% | ||
| Q3 24 | 6.6% | 3.9% | ||
| Q2 24 | 4.2% | 10.8% | ||
| Q1 24 | 1.4% | -3.1% |
资本支出强度
ASTH
ICFI
| Q4 25 | 0.3% | 1.6% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 1.2% | ||
| Q3 24 | 0.5% | 1.0% | ||
| Q2 24 | 0.6% | 1.0% | ||
| Q1 24 | 0.1% | 1.1% |
现金转化率
ASTH
ICFI
| Q4 25 | -0.44× | 4.37× | ||
| Q3 25 | 26.69× | 1.99× | ||
| Q2 25 | 9.65× | 2.20× | ||
| Q1 25 | 2.48× | -1.23× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | 2.11× | 0.78× | ||
| Q2 24 | 1.21× | 2.37× | ||
| Q1 24 | 0.40× | -0.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
ICFI
| US Federal Government | $166.7M | 38% |
| Commercial | $164.4M | 37% |
| US State And Local Government | $78.7M | 18% |
| International Government | $33.8M | 8% |